- Home
- SCYX vs YXT Comparison
SCYX vs YXT Comparison
Compare SCYX & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- YXT
- Stock Information
- Founded
- SCYX 1999
- YXT 2011
- Country
- SCYX United States
- YXT China
- Employees
- SCYX N/A
- YXT N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- YXT
- Sector
- SCYX Health Care
- YXT
- Exchange
- SCYX Nasdaq
- YXT NYSE
- Market Cap
- SCYX 36.8M
- YXT 42.1M
- IPO Year
- SCYX 2014
- YXT 2024
- Fundamental
- Price
- SCYX $0.74
- YXT $0.93
- Analyst Decision
- SCYX
- YXT
- Analyst Count
- SCYX 0
- YXT 0
- Target Price
- SCYX N/A
- YXT N/A
- AVG Volume (30 Days)
- SCYX 170.9K
- YXT 14.9K
- Earning Date
- SCYX 08-07-2025
- YXT 08-21-2025
- Dividend Yield
- SCYX N/A
- YXT N/A
- EPS Growth
- SCYX N/A
- YXT N/A
- EPS
- SCYX N/A
- YXT N/A
- Revenue
- SCYX $2,630,000.00
- YXT $45,374,087.00
- Revenue This Year
- SCYX $463.61
- YXT N/A
- Revenue Next Year
- SCYX $310.80
- YXT N/A
- P/E Ratio
- SCYX N/A
- YXT $1.51
- Revenue Growth
- SCYX N/A
- YXT N/A
- 52 Week Low
- SCYX $0.72
- YXT $0.47
- 52 Week High
- SCYX $2.29
- YXT $11.00
- Technical
- Relative Strength Index (RSI)
- SCYX 37.94
- YXT N/A
- Support Level
- SCYX $0.72
- YXT N/A
- Resistance Level
- SCYX $0.85
- YXT N/A
- Average True Range (ATR)
- SCYX 0.05
- YXT 0.00
- MACD
- SCYX -0.01
- YXT 0.00
- Stochastic Oscillator
- SCYX 9.61
- YXT 0.00
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS
Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.